Shivalik Rasayan Limited has informed the Exchange that Record date for the purpose of Meeting is 20-Sep-2025.
SHIVALIK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shivalik Rasayan Limited announced unaudited Q1 FY26 results (quarter ended June 30, 2025). Standalone net sales grew about 47% YoY to Rs. 4,626 lakhs, but net profit fell sharply to Rs. 122 lakhs (from Rs. 307 lakhs) and EPS dropped to Rs. 0.78 from Rs. 1.97, hit by higher material, employee, and depreciation costs. Consolidated revenue rose about 20% to Rs. 8,991 lakhs, with net profit of Rs. 282 lakhs, helped by the Pharma Formulation segment (via associate Medicamen Biotech). The Board recommended a final dividend of Rs. 0.50 per share (10%) subject to shareholder approval, fixed the 47th AGM for September 27, 2025 (record date September 20, 2025), approved the incorporation of a wholly owned subsidiary for pesticides formulation as a forward-integration move, and re-designated Mr. Ashwani Kumar Sharma as a Non-Executive, Non-Independent Director.
A mixed bag for shareholders – strong revenue growth driven by agrochemicals and the new pharma formulation exposure is offset by a steep fall in profitability, suggesting margin pressure. The new subsidiary for pesticide formulations signals future growth, while the small Rs. 0.50 dividend and the AGM/record date details are routine compliance updates.